[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D017024:Chemotherapy, Adjuvant; D005260:Female; D019788:Fluorodeoxyglucose F18; D005833:Genital Neoplasms, Female / Q000000981:diagnostic imaging*; D006801:Humans; D009362:Neoplasm Metastasis; D018365:Neoplasm, Residual / Q000000981:diagnostic imaging; D010051:Ovarian Neoplasms / Q000000981:diagnostic imaging; D014055:Tomography, Emission-Computed; D014594:Uterine Neoplasms / Q000000981:diagnostic imaging; D014625:Vaginal Neoplasms / Q000000981:diagnostic imaging
D019788:Fluorodeoxyglucose F18